Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

FAUC 213

Copy Product Info
🥰Excellent
Catalog No. T24055Cas No. 337972-47-1
Alias FAUC-213, FAUC213

FAUC 213 is a selective full antagonist of the dopamine D4 receptor.

FAUC 213

FAUC 213

Copy Product Info
🥰Excellent
Purity: 99.84%
Catalog No. T24055Alias FAUC-213, FAUC213Cas No. 337972-47-1
FAUC 213 is a selective full antagonist of the dopamine D4 receptor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$33In StockIn Stock
5 mg$56In StockIn Stock
10 mg$89In StockIn Stock
25 mg$179In StockIn Stock
50 mgPreferentialIn StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.84%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

FAUC 213 AI Summary
FAUC 213 exhibits a diverse pharmacological profile with high selectivity and binding affinity for several human dopamine receptors, particularly the D4 receptor. It binds with a Ki value of 2.2 nM to the human dopamine D4.4 receptor, indicating very strong affinity. Additionally, it displays moderate affinities to dopamine receptors D1 (Ki = 5500.0 nM), D2L (Ki = 3400.0 nM), D2S (Ki = 6300.0 nM), and D3 (Ki = 5300.0 nM). The compound shows partial agonistic activity at the D4 receptor with less than 3.0% mitogenic activity as indicated by [3H]thymidine incorporation. Furthermore, FAUC 213 demonstrates intrinsic activity in a calcium flux assay for the D4 receptor with 19.0% efficacy in the presence of co-transfected G-alpha-qo5 protein, and a substantial selectivity ratio of 489.0 for D4 over D2 receptors. Apart from dopamine receptors, the compound also interacts with other neurotransmitter receptors, including 5HT1A, 5HT2, and adrenergic alpha-1 receptors, suggesting possible broader implications for receptor modulation. Overall, the compound’s high affinity for Dopamine D4 and varied receptor activities highlight its potential therapeutic utility for conditions involving dopamine dysregulation..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
FAUC 213 is a selective full antagonist of the dopamine D4 receptor.
Targets&IC50
D2 receptor (human):3.4 μM (Ki), D4.4 receptor (human):2.2 nM (Ki), D3 receptor (human):5.3 μM (Ki)
SynonymsFAUC-213, FAUC213
Chemical Properties
Molecular Weight326.82
FormulaC18H19ClN4
Cas No.337972-47-1
SmilesClc1ccc(cc1)N1CCN(Cc2cc3ccccn3n2)CC1
Relative Density.1.28g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 3.27 mg/mL (10.01 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0598 mL15.2989 mL30.5979 mL152.9894 mL
5 mM0.6120 mL3.0598 mL6.1196 mL30.5979 mL
10 mM0.3060 mL1.5299 mL3.0598 mL15.2989 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy FAUC 213 | purchase FAUC 213 | FAUC 213 cost | order FAUC 213 | FAUC 213 chemical structure | FAUC 213 formula | FAUC 213 molecular weight